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INTRODUCTION 
Puberty coined from latin word ‘Pubertus’ meaning ‘grown up’ 
(Foster 1992). “Puberty is the period of physiological changes in 
secondary sexual characteristics development and their attainment of 
capability of sexual reproduction”. Puberty not only deals with mere 
physiological changes but there is also tremendous psychological and 
emotional changes in the life of the adolescent. Adolescence, in simple 
words is nothing but the phase of life during which a carefree child 
becomes the responsible adult. 
“WHO defines adolescence as the period in human growth and 
development that occurs after childhood and before adulthood, from age 
10-19 years”. It is an ongoing process i.e; the psychological and 
physiological changes which occur may begin before and even can 
continue after this age( Progress in Obstetrics and Gynaecology, vol 
12; John Studd). 
The biological determinant of adolescence are universal, however 
there may be variation in the duration, defining charactecristics of this 
phase across time, demographic area, culture and socioeconomic 
conditions. Over the passage of time, there have been many changes in 
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the pattern of this period like the time of onset of puberty, urbanization, 
changing attitude towards sexuality, behavior etc. 
Adolescence in girls has been regonised as a special phase in their 
life. It requires a specific approach and special attention. This period of 
transition makes them vulnerable to various problems e.g., general, 
reproductive health related, sexually related and psychological problems. 
This period in a girl’s life is the preparation for safe motherhood. These 
adolescent girls are the direct reproducer for the future generation. So, the 
health of these girls not only influences her own health but, also the 
health of future generation. 
Reproductive health related problems of adolescent girls has its 
own special space in the spectrum of gynaecological problems of all ages. 
This is because of its unique presentation and association with emotional 
and psychological factors. 
Today, adolescent forms 20.9% of total Indian population 
(Population Census of India 2011) and their health determines the 
health of the nation. Adolescent sexual and reproductive health forms a 
major component of global burden of sexual ill health but has been 
historically overlooked in terms of sexual and reproductive health 
intervention . Though, FOGSI has dedicated the year 1999 as the year for 
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adolescent health and addressed the need for adolescent health clinics but 
still it remains a sub specialised area of gynaecology which still needs a 
great deal of attention. 
With this preview, my thesis titled ‘ Study on adolescent 
gynaecological problems’, I have made an attempt to review and analyse 
various gynaecological problems and factors responsible for development 
and progression of these problems in adolescent girls attending 
gyanecological OPD and emergency casualty in ISO & KGH Hospital 
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AIM OF THE STUDY 
 
To study various gynaecological problems encountered in 
adolescent girls who attended the gynaecological out patient department 
of Obstetric and Gynaecology in ISO & Kasturba Gandhi hospital for 
women and children, Triplicane. 
To analyse different causes of the gynaecological problems in 
adolescent girls in age 13-19 years. 
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REVIEW OF LITERATURE 
Puberty is the phase of life in which there is a transition from 
childhood to adulthood. There is development of secondary sexual 
characteristics, onset of menstruation and also the sexual reproduction 
capability. Puberty includes a series of events which are predictable but 
vary in timings, pace and also in sequence. It initiates through a cascade 
of endocrinal changes that leads to sexual maturation and reproductive 
capability   (Patton and Viner 2007) 
 
TIMING OF PUBERTY : 
The age of puberty occurs earlier these days than in the past. It 
generally starts earlier in girls than in boys. There are various 
determinants of the timing of the puberty onset like nutritional status, 
geographical location , general health, exposure to light, psychological 
state. But the major determinant is no doubt genetics. The average age of 
menarche has declined in recent years, according to a study published in 
the journal Paediatrics .This decline in the age of menarche has also been 
attributed to the improved nutrition and healthier living condition  
(Patton and Viner 2007). 
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There has been various researches showing influence of ethnic 
backgrounds, body  mass index , family income on the onset of puberty. 
Menarche occurs earliest in those girls whose BMI falls under the obese 
category( upto 20% above normal weight for age), followed by normal 
weight,  then underweight and lastly the girls who suffers from anorexia. 
But, it is to be noted that the pathological obesity is associated with 
delayed puberty rather than earlier onset. Conditions like chronic illness, 
strenuous physical activity as in atheletes, malnutrition are responsible for  
delayed puberty in some. Puberty starts earlier in those staying in low 
altitude areas than those in high altitude. 
 
PHYSICAL CHANGES OF PUBERTY : 
 The most frequently staging system to describe the physical 
changes of puberty  was described first by Marshall and Tanner in the 
year 1969. The physical change constitute three main components : 
a) Secondary sexual characteristics 
b) Gonadal development and function leading to menarche 
c) Growth spurt 
 The typical sequence includes thelarche ,  adrenarche , growth spurt 
and menarche. 
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PHASES OF PUBERTAL GROWTH:  
Phase 1 ( Thelarche ) : 
The first sign of puberty is the development of breast. It indicates 
the competency of  HPO axis. Marshall and Tanner described the breast 
changes in five stages :- 
Tanner stage 1(B1) : Pre pubertal state, no palpable breast tissue, 
with  areolar less than  2 cm in diameter. 
Tanner stage 2(B2) : Breast budding occurs, visible and palpable 
mould of breast tissue 
Tanner stage 3(B3) : Further enlargement and elevation of the entire 
breast. 
Tanner stage 4(B4) : Projection of areola and papillae to form a 
secondary mould above the level of breast. 
Tanner stage 5(B5) : Breast is mature in contour and proportion.  
Areola receeds into the general contour of the 
breast.  
 
According to the Copenhagen Puberty study (Paediatrics 
Vol.123, No. 5, May 2005), there is a decline in the age at breast 
development. 
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Phase 2 ( Adrenarche ) : 
           It indicates the  rise of  adrenal androgen secretion with a rise in 
blood level of  DHEAS and androstenedione.  This ultimately results in 
the growth of pubic and axillary hair( pubarche ). 
 
Tanner stage 1  : No sexually stimulated pubi hair  
Tanner stage 2 : First appearance of sparse growth of  long coarse 
and crinkly hair along the labia majora. 
Tanner stage 3 : Hair are coarser, darker and curlier extending into 
the the mons pubis 
Tanner stage 4 : Adult type of hair but does not typically extends to 
inner side of the thighs. 
Tanner stage 5 : Adult hair type extending even to inner aspects of 
the thighs 
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Phase 3 ( Growth spurt ) : 
Girls usually reaches peak height velocity in puberty 2 years earlier 
as compared to the boys. Growth hormone, insulin like growth factor 
(IGF-1), and gonadal steroid mainly estrogen plays an major roles. 
Growth spurts preceeds about one years prior to menarche. 
 
Phase 4 ( Menarche ) :  
This is the first menstrual cycle which follows thelarche by about 2 
years. The initial menstrual cycles are anovulatory, this is due to the 
immature HPO axis which may take 1 -5 years to completely mature . 
Onset of menstruation depends on various factors. 
 
Average age of menarche in India 
Study Age  of  Menarche 
Prabhakar  et al , 1972 13.2 years 
Ghosh  et  al , 1973 13.2 years 
Singh  et al , 1987 13.4 years 
Grover  et al , 1989 12.6 years 
Hedge  et al , 1990 13.5 years 
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Phase 5 : 
This is includes complete sexual maturity with ovulatory menstrual 
cycle , full breast development and adult pattern of  pubic and axillary 
hair and complete pubertal growth. 
PHASE DESCRIPTION 
MEAN AGE(INDIAN 
STANDARD) 
I Thelarche 10-11 yrs 
II Adrenarche 11-12 yrs 
III Growth spurt /Peak growth 
velocity 
12-13 yrs 
IV Menarche 11-14 yrs 
V  Mature sexual hair and 
breast 
14-15 yrs 
 
 
GONADAL DEVELOPMENT AND FUNCTION 
During fourth and fifth month of fetal life, there is appearance of 
primordial follicles. It constitutes the life long store of follicles for an 
individual. Thereafter, these follicles grow and enters the antral stage , 
but before menarche they undergo the process of atresia . During puberty, 
follicular growth occurs and forms oocytes which enlarges and forms 
granulosa cells. These follicles undergoes luteinisation during the 
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reproductive life, forming corpus luteum. It is the main source of gonadal 
steroids after ovulation. In the absence of fertilization, these follicles 
undergoes dedifferentiation and cytolysis. 
Ultrasonographic  studies show that during the pubertal  growth, 
there is an increase in the corpus of uterus form an initial tubular form to 
bulbous form. There is increase in the  length of uterus from 2-3 cms  to 
5-8 cms. After the onset of puberty, there is increase in ovarian volume 
from 0.7-0.9 ml to 2-9 ml. According to Yen SSC in 1980, “  normal 
ovarian volume is 4 ml in age group of 12-20 years and around 7.5 ml in 
20-32 years age”.  
 
CONTROL OF GROWTH SPURT IN ADOLESCENT 
The greatest growth occurs in infancy, thereafter it reduces to 
minimal till the beginning of puberty. During puberty, a significant 
proportion  about 17-18% gain in the adult height ( Leon Speroff & 
Marca Fritz, 8
th
 edition 2011). Growth in puberty is controlled by 
complex  hormonal  mechanism  involving growth hormone ,insulin like 
growth factor,  gonadal steroids and thyroid hormones. 
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a) The most important decisive factor of pubertal growth rate is the 
rate at which circulating GH level increases. GH acts by secretion 
of IGF-I ,which promotes growth and differentiation. 
b) Gonadal steroid  act via induction of GH secretion and limiting the 
adult height by stimulating epiphyseal fusion. 
Marshall and Tanner (1969) showed that the mean age for attaining 
peak height velocity in girls was between 12-14 years. 
 
SEQUENCE OF PUBERTAL MILESTONES 
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BEHAVIOURAL CHANGES OF PUBERTY : 
Adolescence is a difficult time for both the child as well as parents 
as it involves not only profound physical changes but also triggers 
emotional,  cognitive, and behavioural changes Patton and Viner 2007. 
This alternation in the cognitive processing clearly are associated  with 
change in attitude of adolescents to not only themselves but also towards 
others. The psychosocial changes during puberty predispose to increased 
incidence of depression, twice more common in girls as in boys. 
 
HORMONAL AND METABOLIC CHANGES IN 
PUBERTY : 
Puberty is the stage which extends from sexual differentiation and 
the ontogeny of  the hypothalamic- pituitary- gonadal  axis to completion 
of the sexual maturation.  Development of hypothalamic-pituitary- portal 
venous axis results in dramatic rise in FSH and LH in fetal pituitary 
gland, but it falls around term due to negative feedback effects of 
estrogen and progesterone derived from placenta. It remains suppressed 
in early infancy. This pre-pubertal pause lasts about approximately one 
decade. The HPO axis in girls develop in two distinct stages during 
puberty: 
1) Gonadal steroid dependent negative feedback mechanism 
2) Intrinsic CNS inhibitory mechanism. 
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COMMON PROBLEMS ASSOCIATED WITH PUBERTY 
1) Delayed Puberty : 
Delayed puberty in girls may be defined as the absence of physical 
manifestation of puberty by the age of 13years, or the absence of 
menstruation by the age of 16 years in the presence normal sexual 
growth.  
Causes includes:- 
a) Constitutional delay (commonest cause) 
b) Hypogonadotropic-Hypogonadism  
c) Hypergonadism-Hypogonadism (Primary gonadal failure) 
Constitutional delay which is by far the most common cause of the 
delayed puberty is considered to be due to physiological immaturity or 
functional deficiency of gonadotropin hormone. Such girls frequently 
give history of delayed menarche in their mother or sisters. 
 
Evaluation of Delayed Pubertal Development: 
1) Evaluation starts with careful history taking, which must also 
includes complete family history. Emphasis should be given on the 
age at the pubertal milestones in other siblings and also parents too. 
2) A thorough physical examination. 
3) Bone age measurement. 
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Laboratory evaluation and Imaging : 
1) Measurement of serum FSH, LH, Estradiol, TSH, free 
thyroxine(T4), prolactin , DHEA-S( wherever indicated). 
2) X-ray of bone 
3) Karyotype 
4) MRI or Cranial CT scan (when indicated) 
 
Treatment: 
1) Reassurance and psychological support to the girl as well as the 
parents. 
2) Correct specific cause if diagnosed such as thyroid hormone 
supplementation in case of hypothyroidism, dopamine agonist in 
hyperprolactinemia, neurosurgical procedure in operable cranial 
tumors etc. 
3) Hormonal therapy – It promotes the age related secondary sexual 
development ad also induce growth. 
Oral estrogen 0.25- 0.5 mg is given, increasing gradually at an 
interval of 3-6 month according to response ( Tanner stage, bone 
age). 
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Progestin in general is started only after the commencement of 
menses, or after 12-24 months of estrogen therapy in order to 
ensure that it does not interfere with the development process of 
breast. After the accomplishment of breast development and  
establishment of menstruation, hormonal therapy can be 
discontinued for 1-3 months at intervals, in order to observe 
commencement of spontaneous menses , as expected in case of 
constitutional delay of puberty. Persistent hypogonadism even after 
age of 18 years suggests congenital GnRH deficiency.  
 
2) PRECOCIOUS PUBERTY: 
It is defined as the occurrence of pubertal growth  ≥2.5 standard 
deviations earlier than the average age.It is more common among 
girls than in boys ( Speroff  et al 1999). 
Classification:- 
a) Gonadotropin- dependent precocious puberty- also known as 
“Central or True Precocious Puberty”. It is due to early 
maturation and activation of  HPO axis, and development of 
both breast and pubic hair. They are isosexual, consistent with 
the actual gender of the child. 
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b) Gonadotropin- independent precocious puberty- also known 
as “Peripheral or Pseudo Precocious Puberty”. It is the result of 
early exposure of sex steroid, independent of GnRH and 
gonadotropins ending up in early sexual development. They 
may be isosexual or contrasexual. 
Evaluation :  
a) Clinical, medical and family history  
b) Physical examination including Tanner staging and measurement 
of bone age. 
c) Endocrinal evaluation : Basal gonadotropin level 
  : Serum LH 
  : Thyroid function test 
  : GnRH stimulation test 
  : Serum estradiol, DHEA-S, testosterone, 
cortisol in gonadotropin- independent 
precocious puberty. 
d) Imaging : i) MRI brain 
   ii) Abdominal and pelvic ultrasonography. 
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Treatment: 
The aim of treatment is to slow down the development until the girl 
is of normal pubertal age, to maximize adult height, and to reduce risk of 
psychological problems associated with early sexual maturation. 
Reassurance and psychological support to both the adolescent girl and 
parents is an important aspect of the treatment.  
GnRH agonist therapy is the drug of choice in cases of GnRH 
dependent precocious puberty (Michael, Thomas & Robert et al). 
 
MENSTRUAL CYCLES : 
Menarche is coined from greek word ‘men’ meaning ‘ moon’ and 
‘arkhe’ meaning ‘beginning’. The normal menstrual cycle results from 
complex feedback mechanism involving the hypothalamus , pituitary , 
ovary and uterus. According to Zarcharias  et  al (1970) , regular 
menstruation was shown to occur little more than a year after menarche. 
Most of the early menstrual cycles are anovulatory. In Vollman’s series 
(1977) , 55% of cycles were anovulatory at gynaecological age 1-2, 
decreasing to 3% at gynaecological age 11-12. Anovulatory  cycles 
usually persists for 12-18 months but can even prolong for 4-5 yrs after 
the menarche. There are variation in the interval between periods, their 
duration and the amount of the blood loss in most of the girls. Such 
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variation are within the physiological limits and requires basic 
investigation and proper counseling. 
According to Metcalfal 1988, “ menstrual dysfunction is common 
in the first 18 months following menarche. As many as 58% of 
adolescents with gynaecological complaints will present as menstrual 
disorder ( Dramusic  et  al 1991). 
 
MENSTRUAL DISORDERS IN  ADOLESCENTS : 
Types of menstrual  disorders  
1. Amenorrhoea 
2. Dysmenorrhoea 
3. Irregular menstrual cycles 
a) Oligomenorrhoea 
b) Polymenorrhoea 
4. Menorrhagia 
 
AMENORRHOEA  IN ADOLESCENTS : 
Amenorrhoea meaning absence of menstruation. It is a symptom, 
not a disease, having various causes. Any of the following criteria needs 
to be fulfilled to be evaluated for amenorrhoea as per Fertility & 
Sterility, 2006 
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a) Absence of menses by age of 13 years in the absence of 
development of secondary sexual character. 
b) Absence of menses by age of 15 years irrespective of presence of 
secondary sexual character. 
c) Absence of menses in a previously menstruated women, for an 
interval of time equivalent to a total of at least three previously, or 
6 month. 
First two criteria falls under primary amenorrhoea, while the third 
one under secondary amenorrhoea.  
 
Etiologies of Amenorrhoea : 
Primary amenorrhoea is usually the result of genetic or anatomic 
abnormality. Etiologies are:- 
i) Abnormalities of HPO axis –  
• Constitutional delay 
• Functional ( stress, exercise, anorexia etc) 
• Kallmann’s syndrome 
• Gonadal dysgenesis 
• Primary ovarian failure 
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ii) Chromosomal abnormalities 
iii) Anatomic abnormalities- e.g. Imperforate hymen, absent vagina, 
transverse vaginal septum, MRKH Syndrome etc. 
iv) Medical disorders – Chronic illness : Juvenile diabetes 
    : Tuberculosis 
    : Thyroid disorders  
v) Enzyme deficiency - 5α- reductase deficiency 
  - 17,20 desmolase deficiency 
Secondary amenorrhoea are more commoner than primary 
amenorrhoea. Causes are divided into:- 
i) Hypothalamic dysfunction – Stress, excessive weight gain / loss, 
tumors. 
ii) Pituitary disorders - Cushing’s disease, adenomas. 
iii) Ovarian disorders – PCOS, Premature ovarian failure. 
iv) Uterine diseases – Tubercular endometritis 
v) Medical disorders – Thyroid dysfunction, chronic illness 
vi) Others – Pregnancy, lactation. 
                                                                                          22 
 
Approach to Patient of Amenorrhoea  
1. History taking :  A thorough  history regarding the patient as well 
as family history should be elicited. It must include girl’s menstrual 
history, physical growth history , previous medical and surgical 
history, etc. 
2. Physical examination : Detail examination of  patient including 
the height / weight/ BMI/ Nutrition /anthropometry and growth 
charts, thyroid, breast  (Tanner staging), hair distribution, 
secondary sexual character ,etc.  
3. Pelvic examination :  
a) Examination of external genitalia : Tanner staging of pubic hair/    
virilization / ambiguous genitalia. 
b) Examination of internal genitalia :  Presence or absence of 
uterus /vaginal septum/ imperforate hymen/absent vagina. 
4) Pregnancy – to be ruled out 
5) Tuberculosis should be looked for. 
6) Hormonal evaluation :  
a) FSH/LH 
b) Serum Prolactin 
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c) Plasma testosterone 
d) DHEAS 
e) TSH, T3 and T4 
f) Serum Progesterone 
g) Estrogen 
The hormonal tests must be done at an appropriate time of 
menstrual cycle. 
7) USG : It is an important diagnostic tool. 
Hormonal assessment : 
• Serum FSH, LH, estradiol – if low then the cause lies in the 
pituitary. 
• If  FSH and LH are high, estrogen is low then – 
a) Evaluate for the bone age, if lower than chronological age, 
then wait and watch. 
b) Kryotyping to rule out Turner’s syndrome. 
                                                                                          24 
 
Treatment: 
The main objective of treatment of Primary amenorrhoea is to 
correct the underlying pathology, if possible, and to prevent complication 
of the disease process. ACOG recommends initial reproductive health 
visit at 13-15 years of age. 
Principles in the management of Primary amenorrhoea : 
1. Identification of underlying disease and treating the cause. 
2. Reassurance : 
Adolescent girls and her parents should be reassured regarding 
anticipated normal pubertal development in case of delay in both 
growth and puberty. 
3. Short –term therapy with sex steroids (estrogens) 
This may be needed in girls with Combination delay of growth and 
puberty (CDGP) to trigger the onset of puberty. 
4. Induction and maintenance of puberty : 
To prevent the early epiphyseal clsure and also avoid psychological 
embarrassment due to the peer pressure, the therapy should be 
started at 13 years of age. 
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The starting dose of ethinyl estradiol is 1-2 mg mg/day, gradually 
increased every 2-3 months. Progestin should be added to either on 
full breast development or after the break through bleeding occurs. 
5) Growth promoting and potentiating strategies : 
In cases like Turner’s syndrome (TS) and  Prader-Willi syndrome 
(PWS) with abnormal physical growth like short stature is 
managed with growth hormone therapy. And to assure maximum 
gain in height, estrogen replacement therapy can be timely added 
for optimum synergistic action and preventing early epiphyseal 
closure. 
6) Prevention of osteoporosis :  
Adolescence is a critical period of bone acquisition depending on 
nutrition, lifestyle and estrogen. Girls with permanent gonadal 
failure need estrogen for not only for maintenance of puberty but 
also for prevention of osteoporosis. 
7) Fertility : 
With newer advancement in the reproductive medicine, a large 
number of patients with pubertal disorders have been assured of 
future fertility. Some of the ways are :- 
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• Induction of ovulation with gonadotropins - in 
hypogonadotropic hypogonadism 
• ART with donor eggs – in hypergonadotropic hypogonadism 
• Trans-sphenoidal surgery – in  Pituitary adenoma 
• Bromocriptine – Hyperprolactinemia 
• Mullerian agenesis – IVF with surrogacy using woman’s own 
egg and husband’s sperm. 
  
DYSMENORRHOEA : 
Dysmenorrhoea is a gynaecological medical condition which is 
characterized by severe uterine pain during menses. In around 5-10%. It 
is severe enough to unable them to attend their normal day today work, 
attend school or college (Sheil & Turner 1996). This kind of 
dysmenorrhoea may lead to fear psychosis in adolescents (Dickens 
1974). 
 Study by Sheil & Turner, 1996 says 20% of these adolescents 
have a family history of dysmenorrhoea either in their mother or sister. 
Dysmenorrhoea can be mild, moderate, or severe depending upon 
the severity, or can be of primary or secondary type depending upon the 
cause. General measures like counseling and reassurance, lifestyle 
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modification are the simple measures to overcome this problem. 
Complete history taking is the most important aspect in the management 
of such cases, includes details about the menses and associated problems. 
But depending upon the severity and associated underlying cause if 
needed, to be treated by pharmacological or surgical management. 
 
Diffentiating features between Primary and Secondary 
dysmenorrhoea 
 
Features Primary Secondary 
Onset First day of menses  Prior to to menses 
Duration 12-24 hours Throughout the menses 
Ovulation Present  Absent 
Pathology  Usually absent Uterine/ pelvic pathology present 
Aetiology Increased PGE2  & 
PGF2α 
Congestion 
Prevalence Most common Less common 
Severity In 5-10% Not so severe 
 
IRREGULAR MENSTRUAL CYCLE 
Menstrual irregularities are the commonest gynaecological 
complain in adolescents ( Dramusic et al 1991). In about 95% of 
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abnormal vaginal  bleeding, the cause is dysfunctional uterine bleeding. 
DUB is a subset of AUB which is defined as excessive, prolonged,or 
unpatterned bleeding  from the uterine endometrium without an organic 
cause. These complains varies from excessive bleeding that is regular 
(menorrhagia), irregular (metrorhagia), combination of both 
(menometrorrhagia) intermittent or sparse cyclical bleeding 
(oligomenorrhoea). The treatment of these disorders varies from mere 
observation to pharmacological and/ or surgical management. About 45% 
of adolescent girls have an anovulatory cycles for approximately 1-2 
years after the onset of menarche (Sheil & Turner 1996), which leads to 
irregular menstrual cycles. There are mainly two types of irregular cycles: 
a) Oligomenorrhoea 
b) Polymenorrhoea 
 
OLIGOMENORRHOEA : 
Oligomenorrhoea is infrequent menstruation. It is defined as the 
periods occurring at a interval of more than 35 days for atleast 6 months 
in a previous normal cycle.This in adolescents are commonly due to 
anovulation but if the history  and clinical examination is suggestive of 
any organic cause further evaluation may be required. 
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Causes of Oligomenorrhoea : 
a) Emotional stress and exercise 
b) PCOS 
c) Thyroid dysfunction 
d) Anorexia nervosa 
e) Adrenal hyperplasia 
f) Pituitary tumors  
g) Excessive weight loss 
h) Obesity 
 
Treatment : 
1) Reassurance : 
 Adolescents and also their parents needs to be counseled properly 
regarding the problem and reassured that this is usually self 
limiting and this is not going to affect their fertility in future, if no 
pathological cause is observed. 
2) Hypothalamic or Pituitary causes :                                   
Due to the rise of expectation from parents , society and peer 
pressure these adolescents are in constant physical and 
psychological stresses leading to defect in pulsatile secretion of 
GnRH, which inturn ends up in oligomenorrhoea. So, this can be 
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managed with proper counseling and behavioral therapy. No drugs 
are required for regularization of menstruation. 
 
3) Hyperprolactinaemia :    
Hyperprolactinaemia in adolescents  is rare but if present can be 
treated with medical drugs like cabergoline, bromocriptine  and 
definitive surgery for prolactinomas, if diagnosed. 
 
POLYCYSTIC  OVARIAN  SYNDROME ( PCOS ) 
Hyperandrogenism is a frequent cause of oligomenorrhoea in 
adolescence. The most common form is the syndrome of PCOS. PCOS is 
a heterogenous disease . It requires special mentioning  because they are 
common in adolescent population. 
Several studies have been performed regarding pathophysiology of 
PCOS but till date no final consensus have been agreed although recently 
familial clusters of PCOS is reported- suggesting a major component of 
its etiology. Steven Frank  study  suggests  the involvement of two key 
genes in the etiology of  PCOS , the steroid synthesis gene CYPIIa and 
insulin gene- Variable number tandem repeats (VNTR). 
PCOS comprise of a wide spectrum of signs which ranges from 
presence of multicystic ovarian morphology detected by USG, to obesity , 
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menstrual irregularities, infertility and to even cardiovascular disorders – 
all due to metabolic disturbances involving increased level of LH, insulin 
and androgen and dyslipidemia. 
Pre-pubertal ovaries are usually multicystic. These multicystic 
ovaries are normal findings in the evolution of mature hypothalamic- 
pituitary-gonadol axis, as described by Merrill. 
Therefore, PCOS is defined as a dysfunctional condition of the 
ovary in which there is increased LH dependent secretion of androgen 
from hyperplastic theca and stromal cells of ovary. 
 
Clinical features of PCOS :- 
a) Hirsutism 
b) Menstrual  irregularities 
c) Central obesity 
d) Infertility 
e) Pelvic examination( if done) – often  normal, as it is uncommon to 
palpate enlarged ovaries in teenagers. 
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Rotterdam criteria (2003) suggests presence of at least two criteria to be 
diagnosed as PCOS, these criteria are :- 
i) Oligo/ amenorrhoea, anovulation, infertility 
ii) Hirsuitism 
iii) USG features of PCOS as described above. 
 
Laboratory Findings :  
Endocrinal Screening : 
Prolactin and TSH levels are tested to rule out pituitary or thyroid 
disease as an etiology of anovulation. 
 
In PCOS  there is – 
• Normal or increased LH 
• Normal or increased 17 ketosteroid 
• Normal or increased FSH 
• Normal or increased E2 
•  Increased LH/FSH ratio 
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Sonographic Findings:  
Typical USG findings in PCOS 
i) No. of cyst = >10mm pushed periphery (Necklace pattern)  
ii) Abnormal  stroma  
iii) Uterine width : ovarian length=<1,  
iv) Increased ovarian volume( > 10 ml),  
v) Increased ovarian roundness index=>0.7 
 
Ovarian Histology :  
Multiple microcysts with atretic and immature follicles , fibrosis 
thickening , and sclerosis of ovarian capsule. 
Treatment : Depends on various factors such as : 
• Age of girl 
• Presence or absence of acne, hirsutism , obesity 
• Menstrual irregularities 
• Presence or absence of hyperinsulinemia or hyperandrogenism or 
high LH 
• Prevention of long-term sequelae. 
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The purpose of treatment is to- 
• Treat menstrual irregularities 
• Treat hirsutism 
• Treat infertility 
• To prevent long term consequences of PCOS.  
Thus, the treatment is modified or prescribed as per the 
requirement of women. It is subdivided into:- 
a) Life style modification 
b) Medical management 
c) Surgical management 
 
Lifestyle modification : 
It include weight reduction, exercise, low calorie diet intake, 
abandoning cigarette smoking etc. Weight reduction has beneficial effects 
on menstrual abnormalities as well as in hirsutism (Guzick, Wing, Berga 
et al 1989). Studies have shown reduction in the level of (a) Serum free 
testosterone (b) Insulin and insulin like growth factor I( IGF-I) and (c) 
increase in the level of SHBG due to intake of very low energy diet in 
girls with PCOS . It has been shown that weight reduction decreased 
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ovarian P450c17a activity and cause decrease serum free testosterone 
level in obese girls with PCOS. 
Weight loss causes for decrease in both hyperinsulinemia and 
insulin resistance, increases SHBG and thus results in overall reduction in 
hyperandrogenism. 
 
Medical Management :  
Most commonly used are metformin which reduces 
hyperinsulinemia and hyperandrogenism independent of changes in body 
weight (obesity) and OCPs for regularization of periods. The usual dose 
of metformin is 500 mg thrice daily and can be gradually increased if 
required. But girl should be cautioned that it make take 6 months or more 
for complete results. And, patients should also be cautioned that it may 
recur, later in reproductive life. 
 
Surgical Management: 
Surgical management is reserved only in following cases: - 
• Medical therapy fails 
• Hyperstimulation following medical treatment 
• Infertility 
• Previous pregnancy loss 
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Surgical procedure comprises of :- 
a) Wedge resection of ovary 
b) Laparoscopic ovarian puncture- for not more than four cysts in 
each ovary either by laser or by unipolar electrocautery. 
But these surgical procedures have disadvantages of forming pelvic 
adhesion postoperatively which may further add on to reduction in 
fertility rate. 
 
SEQUELAE OF PCOS 
Long- term sequelae in PCOS is important to know because mainly 
two reasons:- 
• Higher incidence of PCOS in adolescent (20%) diagnosed by USG 
• Because of its impact on the future reproductive life. 
 
Complication of PCOS 
a) Short- term sequelae –   
i) Obesity 
ii) Hirsutism 
iii) Menstrual irregularities 
iv) Infertility 
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b) Long- term sequelae 
i) Diabetes 
ii) Cardiovascular disease 
iii) Osteoporosis 
iv) Cancer 
 
POLYMENORRHOEA 
Polymenorrhoea is the least common menstrual complaint in this 
age group. It is usually caused by luteal phase defect (LPD). Adolescents 
with such complaints are treated with progesterone support in luteal 
phase. OCPs are used to regularize the cycles. 
 
PUBERTY MENORRHAGIA  
Puberty menorrhagia is the excessive menstrual blood loss between 
menarche and 19 years of age. Menorrhagia is defined as menstrual loss 
greater than 80 ml. Anovulation and bleeding disorders make up the vast 
majority of menorrhagia in adolescent. In adolescents, the HPO axis takes 
time to mature after menarche, which can lead to anovulation.  
In first 2 years after menarche, 55-82% 0f cycles are anovulatory, 
and by fourth and fifth year this decreases to 20% of cycles being  
anovulatory. These patients generally lack the positive feedback  
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mechanism necessary to initiate an LH surge and subsequent ovulation 
despite increased follicular estrogen levels. But, the negative estrogen 
mechanism is intact in these patients. These are hypothalamic problems 
rather than pituitary as indicated by normal GnRH stimulation. 
Unopposed estrogen stimulates endometrial growth, which ultimately 
outgrows its blood supply. The endometrium becomes excessively 
thickened and unstable , and the lining breaks down irregularly and 
unpredictably. This leads to heavy bleeding and prolonged menstruation. 
 
Causes of Puberty Menorrhagia : 
• Anovulatory uterine bleeding 
• Coagulation disorders – Von willebrands disease (32-100%) 
  – Idiopathic thrombocytopenic purpura 
  – Platelet disorder-e.g. Bernard –Soulier 
Syndrome (51%), Glanzmann’s 
thrombasthenia(98%) 
• Endometrial tuberculosis 
• Thyroid dysfunction 
• Pregnancy (In cases of heavy bleeding, adolescent pregnancy 
should always be ruled out.) 
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History & Physical Examination:  
The evaluation of the adolescent with menorrhagia should begin 
with detailed history. It is important to assess family history for presence 
of any known bleeding disorders. Upon physical examination, height, 
weight, BMI, orthostatic blood pressure and pulse should be recorded. 
Examination of major body systems gives insight to endocrinological or 
systemic disease. 
  
Investigation : 
1) Complete blood count , 
2) coagulation profile ( bleeding time, clotting time, PT, ApTT), 
3) Thyroid function test( TSH ,FT4,FT3) 
4) Ultrasonography of pelvis are useful parameters. 
 
If history indicates a bleeding disorder, if bleeding is severe, 
prolonged or associated with menarche, or if initial screening is 
abnormal, specific laboratory test for coagulation defects should be done. 
In developing countries like of ours, where tuberculosis is still highly 
prevalent, it is a routine test to rule out tuberculosis by laboratory tests 
like montoux, chest X-ray, and even TB-PCR of the first day menstrual 
blood. 
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Treatment : 
The goal of initial assessment is to determine which adolescent 
needs treatment and which adolescent can be observed until the 
maturation of HPO axis results in regular normal menses. 
1) Counseling and reassurance - In most of girls this is the only 
therapy required. 
2) Anaemia is corrected with iron supplementation and high protein 
diet and if required blood transfusion is suggested. 
3) NSAIDS like mefenamic acids, antifibrinolytic such as tranexamic 
acid and aminoaproic acid , can reduce menstrual  blood loss by 
50%. 
4) Acute bleeding is stopped by 5-10 mg of norethisterone  
medroxyprogesterone orally. Later on, cyclic progesterone therapy 
is recommended 
5) Hormonal therapy: Hormonal therapy is the most effective 
therapy, with more than 93% of adolescents responding to some 
form of hormonal treatment. Indication for start of  hormonal 
therapy are as follows:- 
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a) Anaemia 
b) Recurrence 
c) Restricted routine activities 
The initial treatment is the use of oral medroxy progesterone 
acetate followed by the use of combined oral contraceptive pills. OCPs 
can also be used as a first line of treatment in treating menorrhagia in 
adolescents with bleeding disorders.  
If OCPs are contraindicated, or the patient or family does not wish 
to start oral contraception, cyclic progestins can be used.Oral 
medroxyprogesterone acetate 5mg can be given for 10-14 days or 21 days 
each month to induce a withdrawal bleeding that is cyclic and predictable. 
This pattern is continued for 3-6 months. 
6) Diagnostic curettage ( Sheil & Turner 1996) is rarely indicated 
in non responder to  hormonal therapy in these  age group patients. 
If endometrial hyperplasia is seen then she is put on progesterone 
for a period of 6-12 months, after which she re-evaluated. 
Careful assessment and prompt recognition is important in the 
adolescent with menorrhagia. No single therapy or treatment is 
universal, and it must be tailored to the adolescent and clinical 
situation. 
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INFECTION IN ADOLESCENT : 
Due to lack of oestrogen and alkaline vaginal secretions, young  
girls are more prone to infection in the pre menarche period . Vaginal 
discharge is generally the result of infection caused by non specific 
causes, resulting from poor hygiene or as a result of specific infection. 
Aetiology : 
1) Chemical / Irritant ( or Allergic ) 
2) Poor hygiene :  
Poor personal hygiene may lead to candidal vulvovaginitis, vulval 
irritation may follow worm infection like pin worms , thread 
worms secondary to anorectal contamination. 
3) Infection : 
Infection of vulva and vagina i.e, vulvoginitis  most commonly due to 
the infection caused by the normal vaginal flora, which includes mixed 
aerobes and anaerobes, commonly staphylococcus epidermidis, 
lactobacilli, bacteroides etc. Sexually transmitted infections like that 
caused by Neisseria  gonorrhoea, Chlamydia trachomatis, 
Trichomonas vaginilis. 
    
4) Foreign bodies 
5) Sexual abuse 
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Diagnosis : 
a) Detailed history including sexual ativity, type of discharge, use of 
antibiotics, concomitant infection elsewhere in body, treatment taken 
etc. 
b) Clinical examination – with utmost care. P/R  Examination  may be 
required. 
c) Vaginal or urethral discharge collected and wet smear examined in 
microscope. 
d) Examination under anaesthesia may be required if  suspicion of 
foreign body in vagina or foul smelling discharge is present. 
 
Management :  
 Appropriate antibiotics for specific organism. 
 Non specific Infections :  improve hygiene of private parts. Local 
application of estrogen cream 0.10% for 
2-3 weeks. 
 Specific infections : Trichomoniasis : Metronidazole 20 mg 
three times a day for 7 days Alternative 
single dose of 2 gm of metronidazole. 
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 Candidiasis : Oral nystatin 5 lac units three times a day 
for two weeks or oral fluconazole. 
Locally clotrimazole or miconazole 
cream for 6-12 days. 
 
OVARIAN MALIGNANCIES IN ADOLESCENT : 
Total incidence of ovarian cancer in adolescents ranges from 95 to 
225 per million person years and highest being recorded in Australia and 
Israel, and lowest in India and Japan.  
Ovarian neoplasm accounts for approximately 1%  of all malignant 
tumors in girls aged 17 years or below ( Young & Miller, 1975). 
Ovarian  masses may be of benign or malignant. Dealing with 
ovarian tumors in adolescents is particularly a challenge because of its 
rarity, atypical symptoms, malignant potential, and probable serious 
outcome on the patient’s reproductive life. 
Functional ovarian cysts are the most common benign ovarian 
masses detected in adolescents. Amongst all age group, adolescents have 
the highest rates of PID which pre-disposes them to develop tubo- 
ovarian abscess. As far as true ovarian tumors are concerned , they 
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comprise 1.5%  of all adolescent tumors with an absolute incidence of 
approximately 5.5%. 
 
Clinical Presentation : 
Ovarian neoplasia  are known for their silent presentation and 
detected mostly as an incidental finding. Commonest presentation will be 
the complain of  only vague abdominal discomfort or bloating sensation 
which is invariably treated with antispasmodics and antiflatulents. The 
presenting complaints are pelvic pain, pressure symptoms on bladder or 
rectum, menstrual irregularities etc. The vast majority of children with 
malignant ovarian tumors are detected at an advanced stage as in majority  
of cases it doesn’t show symptoms till it reaches advance stage. However 
it has now become clear that ovarian neoplasms also cause particular 
symptoms in particular stages of disease progression. Keeping this fact 
into mind, Symptom index has been developed for screening of ovarian 
cancer  is under trial in USA. Torsion may occur in as many as 35 to 45% 
of ovarian tumors in adolescents. These cases are wrongly diagnosed as 
suffering from appendicitis. The use of imaging modalities such as X- ray 
and ultrasound will increase the diagnostic accuracy to 80%. 
According to National Cancer Institute’s SEER program, 
cancer statics review(1973-1988), the most common tumors in 
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adolescent females (15 -19 years) are germ cell tumors (15%). 
Dysgerminoma are the most common malignant  germ cell tumors, which 
account for about 30-40% of all ovarian cancers of germ cell origin. 
Dysgerminoma destroy the ovarian tissue may cause amenorrhoea which 
must be differentiated from tuberculosis which often presents as an 
abdominopelvic mass due to encysted ascites. 
Endodermal sinus tumor of ovary are also common germ cell 
tumor seen in paediatric and adolescent age group. They grow rapidly and 
present usually as abdominal or pelvic pain or abdominal enlargement. 
Asymptomatic pelvic pain is seen in 100%. Granulosa cell tumors present 
as precocious puberty in young adolescent or as abnormal vaginal 
bleeding in the older adolescent. It accounts for about 1-2% of all ovarian 
malignancies. 
 
Investigation : 
Baseline investigation should always include pregnancy test 
regardless of elicited sexual history. USG, CT Scan, MRI forms the 
cornerstone  for evaluation  of the exact size, location, internal 
consistency, relationship with other structures and also spread to other 
organs ( metastasis). Chest radiograph should be done. Abdominal X-ray 
for visualizing calcifications in teratomas. 
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Tumor markers are an important laboratory investigation which are 
extremely useful in monitoring ovarian neoplasms. CA 125, 
alphafetoprotein, human chorionic gonadotrophins( HCG) are such tumor 
markers which are elevated in specific malignancies. CA125 is elevated 
in epithelial tumors . HCG and alphafetoprotein are raised in endodemal 
sinus tumor and non gestational choriocarcinoma. 
 
Management :  
The main aim of management of ovarian tumor is to conserve the 
reproductive potential without jeopardizing her life. Asymptomatic cystic 
adnexal masses requires only observation  as these are always benign and 
regress spontaneously in 3-6 months or promotes regression with oral 
contraceptives for 3 months. 
Surgery is indicated in following conditions : 
• Ovarian cyst > 6 cm without regression for 6-8 weeks 
• Any cystic lesion > 10 cm 
• Solid ovarian lesion   
• Ovarian lesion with papillary excrescences in its wall 
• Bilateral 
• Presence of ascites 
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Usually cystectomy is the choice of surgery in order to preserve her 
reproductive potential. Benign conditions should be managed by 
conservative surgery either by laparoscopy or laparotomy. Surgery like 
salphingo oopherectomy is consider in cases associated with torsion and 
infarction. 
Endometriosis in adolescent is managed primarily by non surgical 
methods and includes prolonged suppression of ovulation. Mature cystic 
teratomas are managed surgically by only removal of the affected gonad 
with preservation of ipsilateral tube. In case of teratomas, close inspection 
of the contralateral ovary should be done for evidence of bilateral disease.  
 
Fertility preservation surgeries in adolescent girls: 
Preservation of fertility in adolescent girls has been a matter of 
great concern for the gynaecologist dealing with them, at the risk of 
ovarian damage. In adolescent girls, fertility may be impaired by repeat 
ovarian surgeries ,use of gonadotoxic treatment or genetic disorders. In 
recent times, various options have emerged in order to preserve fertility in 
teenage girls like cryopreservation of embryos, mature and immature 
oocytes and ovarian cortex prior to use of gonadotoxic therapy. 
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Cryopreservation of ovarian tissue has been proposed for 
adolescent girls suffering from Turner’s syndrome, especially the mosaic 
type. 
Treatment of cancer in adolescents should be a multi-disciplinary 
settings and is based on the degree of malignancy. The primary treatment 
is surgery with proper staging. In advanced cases of malignant germ cell 
tumor , which is associated with metastasis, ascites etc surgery is 
followed by post operative radiation therapy as these tumor are 
radiosensitive. But the major disadvantage of radiation therapy is the loss 
of fertility. So, now the treatment of choice is the combination 
chemotherapy eg. BEP,VBP,VAC. 
Adolescents treated for ovarian tumors should be closely followed 
up, particularly if ovarian preservation was attempted. In the follow up, 
detailed history , thorough clinical examination, USG and specific tumor 
marker should be done. 
 
Adolescent Sexuality : 
Adolescence is a critical time when there is curosity and increase in 
sexual drive. This time offer an ideal window of opportunity for building 
the foundation of sexual and reproductive health in adolescents. The 
burden of adolescent sexual behavior are an enormous burden on both 
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adolescent and the society. Developmentally, adolescent reaches physical 
maturity before they are cognitively able to appreciate the consequence of 
their behavior. A teenager’s major source of information regarding 
sexuality is his or her peer group, all of whom are experiencing and 
reinforcing the same behaviors. The family, the major socialize of other 
behaviors is not as powerful a force in shaping responsible sexual 
behavior because of parental discomfort in sex education and sexual 
discussion. A healthy attitude towards healthy sexual interaction, and 
awareness of their behavior and needs, followed by counseling can 
prevent many traumatic consequences. 
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MATERIALS AND METHODS 
A total of 150 cases of adolescent girls aged 13-19 years who 
attended  gynaecological OPD and emergency department in ISO & KGH 
hospital, Triplicane were included in the study. 
 
Study Design :  
Prospective study. 
 
Inclusion Criteria :   
Married / unmarried, non –pregnant, non  lactating adolescent girls 
aged 13-19 years. 
 
Exclusion criteria :  
Teenage pregnancy 
 
History :  
            Detailed history with regard to the gynaecological problems was 
taken from the patient and girl’s mother was also interviewed to get 
accurate details about any previous  medical problems if present. 
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Physical Examination : 
A thorough clinical examination including height, weight, 
secondary sexual character, general examination of breast, thyroid, 
cardiovascular system, respiratory, and central nervous system or any 
congenital anomalies were noted. 
Body mass index (BMI) or quetelet index was calculated using the 
formula:- 
Weight in kg 
BMI = 
(Height in cm)
2
 
 
General examination comprising  thyroid examination, presence of 
hirsutism, pubertal stage of breast and pubic hair were graded according 
to Marshall and Tanner staging. External genitalia examined. Per 
abdominal examination done to rule out any mass. Per rectal and 
bimanual pelvic examination done whenever indicated. 
Then patients were subjected to various investigations like 
haemogram, coagulation profile, hormonal assays, and ultrasonography 
depending on diagnosis clinically.  
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Amenorrhoea cases were referred to endocrinologist and genetic 
counseling done. For all cases, relevant investigation like karyotyping 
was done and the diagnosis confirmed. Patients were also referred to 
haematologist, oncologist in those indicated. 
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OBSERVATIONS 
Table 1 : Age Distribution 
Age in years No. of patients Percent 
13 11 7.3 
14 12 8.0 
15 21 14.0 
16 18 12.0 
17 35 23.3 
18 25 16.6 
19 28 18.6 
Total 150 100.0 
 
The table shows the age distribution in the study group. It ranged 
from 13- 19 years of age. Maximum number of adolescent girls attending 
the gnaecology OPD in KGH were of 17 years of age (3/150), followed 
by girls with age of 19 years( 28/150). 
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Chart 1 : Age Distribution 
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This bar diagram shows the diagramatic representation of age 
distribution among the  adolescent girls in the study group. Maximum 
incidence is of 17 years. 
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Chart 1 : Age Distribution 
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The bar chart depicts that the, adolescent girls of age group 17 
years attending  Gynaecology  OPD were maximum (23.3%). 
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Table 2 : Socioeconomic status 
Socioeconomic  
Status 
No. of Patients Percent 
III 21 14.9 
IV 80 53.3 
V 49 32.6 
Total 150 100.0 
 
In the present study, all the girls were mostly from family with 
lower socio economic status either from Class-III / IV / V.  
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In the present study majority of adolescent girls came from low 
socio economic background with highest number of 80 cases under  
Class-IV socio economic status (80/150). 
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Out of 150 adolescent girls, 14.9% belonged to class III socio 
economic status, 53.3% belonged to class IV, 32.6% belonged to class V 
socio economic status. 
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Table 3 : Educational Status 
Education No. of patients Percent 
 Primary 19 12.6 
 Secondary 80 53.3 
Higher secondary 51 34.0 
Total 150 100.0 
 
This table shows the number of adolescent girls in the study group 
with their educational status. Though literacy rate among the adolescent 
girls was found to be 100 percent, but percentage of school dropouts were 
3.33% ( 5/150). 
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Chart 3 : Educational status 
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In the present study, majority of girls were studying in secondary 
standard (80/150), followed by girls with higher secondary educational 
status.
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Chart 3 : Educational status 
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This pie chart represents that maximum percentage (53.3%) of 
adolescent girls in the present study group were having educational status 
as secondary standard. 
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Table 4: Demography 
Place of living No. of patients Percent 
Urban 117 78.0 
Rural 33 22.0 
Total 150 100.0 
 
Majority of the adolescent girls under study belonged to urban area 
(78.0%) 
Chart 4: Demography 
78%
22%
Urban
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This pie chart shows that maximum percent (78.0%) of adolescent 
girls in the study group came from the urban population. 
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Out of 150 cases studied, 117 girls came from the urban area and 
rest of 33 girls were from rural area in and around of KGH, Chennai. 
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Table 5 : Body mass index (BMI) 
BMI No. of patients Percent 
  Under weight(≤19) 39 26.0% 
   Normal (20-24) 84 56.0% 
   Overweight (25-29 ) 22 14.6% 
    Obese (30-34 ) 3 2.1% 
    Morbid obesity 
(≥35 ) 
2 1.3% 
   Total 150 100.0% 
 
In the study group, adolescent girls were categorized into normal, 
underweight, overweight, obese and morbidly obese, as per their BMI 
calculated using weight measured in Kg and height in cm. 
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Chart 5 : Body mass index (BMI) 
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 Out of total 150 cases of adolescent girls, majority (84/150) were 
having normal BMI, followed by (39/150) underweight, overweight 
(22/150). There was only few cases of obesity (3) and morbid obesity (2). 
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Among the 150 adolescent girls in the study group, maximum 
percent of girls had normal BMI (56.0%), 17.6% had higher range of 
BMI while about 26% were underweight. 
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Table 6 : Anaemia incidence (Hb% estimation) 
Anaemia No. of Patients Percent 
Severe 4 2.6 
Moderate 80 53.3 
Mild 38 25.3 
Normal 28 18.6 
Total 150 100.0 
 
Majority of the adolescent girls under study were anaemic, which 
ranged from mild to severe type based on the haemoglobin estimation. 
• 28/150 cases had no anaemia with hb% ≥12 gm%. 
• 38/150 cases had mild anaemia with hb% ranging from11-
11.9 gm%. 
• 80/150 cases had moderate anemia with hb% ranging from 
8.1-10.9 gm%. 
• 4/150 cases had severe anaemia  hb% <8 gm% 
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Moderate type of anemia with haemoglobin percent ranging from 
8.1-10.9 gm% were most prevalent among the study group. 
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Majority of the adolescent girls under study were anaemic, 25.3% 
had mild anaemia, 53.3% (maximum) had moderate anaemia and 2.6% 
suffered from severe anaemia. Only 18.6% of cases were not anaemic as 
per the Hb% estimation. 
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Table 7: Presenting complaints in the study population 
Complaints No. of Patients Percent 
Menstrual complaints 147 59.2% 
Vaginal discharge 51 20.5% 
Lower abdominal pain 14 5.64% 
Urinary problem 15 6.04% 
Weight problem 14 5.64% 
Others 7 2.82% 
Total 248 100.0% 
 
 
In the present study, various presenting complaints among the 
adolescent girls were depicted in the table. Most common presenting 
complaints among the teenage girls was menstrual complaint. Majority of 
girls were having one or more morbidity. 
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In the present study, girls were allowed to have multiple responses 
regarding their presenting complaints. Menstrual complaints the most 
common complaint ( 147) among  the study group attending the OPD, 
followed by complaint of white discharge p/v (51). 
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Majority of the girls had menstrual complaints 59.2%, followed by 
second common complaint was vaginal discharge 20.5% and then 
followed by urinary tract infection 6.04%. 
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Table 8 : Types of menstrual dysfunction 
Menstrual disorders No. of patients Percent 
Amenorrhoea 9 6.12 
Menorrhagia 32 19.04 
Oligomenorrhoea 81 55.1 
Hypomenorrhoea 1 0.68 
Dysmenorrhoea 24 16.3 
Total 147 100.0 
 
Menstrual complaints being the most common complaints among 
the studied adolescent group of girls. Menstrual complaints ranged from 
amenorrhoea to menorrhagia. Dysmenorrhoea was also included in this 
category.  
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Among the menstrual complaints, the most common type of 
complaint was that of oligomenorrhoea (81/147), followed by 
menorrhagia. 
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Chart 8 : Types of menstrual dysfunction 
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Majority of girls were suffering from oligomenorrhoea (55.1%) 
followed by those presenting with menorrhagia (19.04%) 
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Table 9 : Association between BMI and PCOS  among the study 
group with menstrual complaints. 
 
BMI 
No. of 
patients 
Percent 
Chi-square 
Value 
P Value 
Under Weight 1 3.6% 
Normal 14 50.0% 
Over Weight 8 28.6% 
Obese 3 10.7% 
Morbid Obesity 2 7.1% 
Total 28 100.00% 
28.294 0.000 
 
 
A highly significant statistical association between BMI and PCOS 
was seen. Adolescent having higher BMI had increased incidence of 
PCOS in the USG.  
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Chart 9 : Association between BMI and PCOS  among the study 
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Table 10 : Etiology of Amenorrhoea 
Etiology Karyotype 
No. of 
patients 
Percent 
 Mullerian agenesis 46 XX  4 44.4 
Turner syndrome 45 X0 2 22.2 
 Turner mosaic 45 X0 / 46 XX 1 11.1 
Constitutional delay 46 XX 1 11.1 
Pure gonadal dysgenesis 46 XX 1 11.1 
Total  9 100.0 
 
Commonest cause of primary amenorrhoea in this study group 
were Mullerian agenesis (44.4%). 
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Chart 10 : Etiology of Amenorrhoea 
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Out of 9 cases giadnosed with primary amenorrhoea in the study 
group.the commonest cause was MRKH syndrome. 
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Chart 10 : Etiology of Amenorrhoea 
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In the present study, maximum percent (44.4%) of cases 
amenorrhoea  was diagnosed with mullerian agenesis, followed by 
Turner’s syndrome (22.2%). 
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Table 11 : Etiology of Menstrual dysfunctions 
                Etiology No. of patients Percent 
Dysfunctional uterine 
bleeding 
86 74.7 
PCOS 24 20.8 
Thyroid disorder 4 3.47 
 Hyperproactinemia 1 0.86 
 Total 115 100.0 
 
This table shows various causes for the menstrual irregularities in 
the adolescent girls under study. Most common is the Dysfunctional 
uterine bleeding. 
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Table 11 : Etiology of Menstrual dysfunctions 
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Out of the total 115 case of menstrual dysfunction, 86 cases were 
due to dysfunctional uterine bleeding without any pelvic pathology 
followed  by PCOS (24)  which was the second most common cause for 
the menstrual disorder in the adolescent age group under study. 
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Table 11 : Etiology of Menstrual dysfunctions 
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Commonest cause of menstrual dysfunction in the adolescent girls 
under study was dysfunctional uterine bleeding without any pelvic 
pathology (74.4%). 
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Table 11 : Age in years  and dysmenorrhoea in adolescent girls 
Age group in years Total no of cases 
No. of cases with 
dysmenorrhoea 
13-15 years 42 6 
16-19 years 99 1 8 
Total 141 24 
 
In the present study, the prevalence of dysmenorrhoea is higher in 
the adolescent girls of age group between 16-19 years. 
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Table 12 : Age Group in years and Irregular Periods in Adolescent 
Girls 
Age 
group in 
years 
No. of 
cases with 
irregular 
periods 
% within 
age group 
in years 
% 
within 
irregular 
periods 
count 
Chi 
square 
value 
P-value 
13-15 
years 
19 45.2% 22.4% 
16-19 
years 
66 77.6% 66.7% 
5.656 0.017 
 
There is a significant statistical association between the age group 
in years with complain of irregular periods. 
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Chart 12 : Age in years and irregular menstrual complaints in 
adolescent girls 
 
No. of cases with irregular periods
19
66
0
10
20
30
40
50
60
70
13-15 years 16-19 years
No. of cases with
irregular periods
 
 
 
% within irregular periods count
22%
67%
13-15 years
16-19 years
                                                                                          88 
 
 
 
Table 13 : Age in years and Puberty menorrhagia 
 
Age group 
in years 
No. of cases 
with puberty 
menorrhagia 
Percent 
Chi square 
value 
P- value 
13-14 years 8 25% 
16-19 years 24 75.0% 
Total 32 100% 
8.000 0.005 
 
 
 
There is a significant statistical association between age group in 
years and puberty Menorrhagia. 
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Chart 13 : Age group in years and Puberty menorrhagia in 
adolescent girls under study. 
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This chart shows that puberty menorrhagia were more common in 
age group of 16- 19 years  i.e; 24 out of all 32cases of puberty 
menorrhagia. 
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Table 14 : Causes of oligomenorrhoea 
Cause No. of cases Percent 
HPO axis dysfunction 60 74.07 
PCOS 13 16.04 
Hypothyroidism 4 4.93 
Hypothyrooidism with PCOS 3 3.70 
Hyperprolactinemia 1 1.23 
Total 81 100.0 
  
In the present study 81 cases of oligomenorrhoea were studied. 
Commonest cause of oligomenorrhoea was HPO axis dysfunction 
74.07% , followed by PCOS accounting for 16.04%. 
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In the present study , the main cause for oligomenorrhoea among 
the study group of adolescent girls was the immaturity of hypothalamus –
pituitary-ovarian  axis (74.7%). 
 
                                                                                          92 
 
 
 
 
Table 15: Association between anaemia and puberty menorrhagia 
Anaemia 
No of cases with 
menorrhagia 
Chi square value P-value 
Normal  1 
Mild 2 
Moderate 28 
Severe 1 
Total 32 
66.750 0.000 
 
 
There is highly significant association between the anemia status 
and the puberty menorrhagia. 
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Table 16 : BMI in the study group and oligomenorrhoea 
BMI No. of cases Percent 
≤ 19 20 25.9% 
20-24 44 54.325% 
25-29 10 12.34% 
30-34 5 6.17% 
≥35 2 2.46% 
Total 81 100.0 
 
Out of 81 cases of oligomenorrhoea 44 cases had normal BMI, 20 
were underweight and 17 had BMI higher than the normal.  
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BMI in Study Group with Oligomenorrhoea
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In the present study 54.3% of cases with oligomenorrhoea had 
normal BMI, 25.9% had were underweight and 20.9% had BMI higher 
than normal. 
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Table 15: Ovarian tumors in the study group 
Tumors No. of cases Percent 
Ovarian malignancy 2 40.0% 
Twisted ovarian cyst  1 20.0% 
Simple serous cyst 2 40.0% 
Total 5 100.0% 
 
In this study, 5 adolescent girls were diagnosed with ovarian tumor 
( benign or malignant). Most common type of ovarian tumor found in the 
present study was simple serous ovarian cysts (2/5). Out of the two 
malignant ovarian tumor, 1 case was of Juvenile granulose cell tumor fig. 
1(a) and 1(b) and other was Yolk sac tumor fig.2(a) and 2(b).             
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 Fig. Gross image of Juvenile Granulosa Cell Tumour of ovary  
 
Fig : Microscopic image  
 Many follicles are lined by cells with atypical ‘ hobnail’  nuclei simulating a 
tubulocystic clear cell arcinoma 
  
 
Fig 2a : Yolk sac tumour of ovary 
 
 
 
Fig 2( b):  Yolk sac tumour of ovary with Schiller duval bodies 
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DISCUSSION 
This study was conducted at ISO & Government Kasturba 
Gandhi Hospital for Women & Children to analyse the various 
gynaecological problems prevalent among the adolescent girls 
and to know various cause and factors associated with it. 
In the present study, maximum incidence of 
gynaecological problems was seen in the age group of 17 years 
(23.3%). About  3.33% of girls were school drop outs. Majority 
of them belonged to family of Class IV socio-economic status 
and 78.0% came from urban areas. 
Disturbances of menstruation, either physiological or 
pathological, are the most common presenting complaint in 
adolescent gynaecological clinic. The present study shows that 
menstrual disorders are the most common gynaecological 
dysfunction among the adolescent girls( 62.3%). These ranges 
from amenorrhoea to menorrhagia. 
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1) Primary Amenorrhoea : 
 In present study amenorrhoea accounted for 4.28% (9/150) of 
cases, in comparison to that reported by Sebanti et al (6.45 %) and 
study by Archana  et al  (6.25%). Out of the total of 9 cases of Primary 
amenorrhoea, four cases was found to be of diagnosis Mullerian 
dysgenesis. Two cases were diagnosed as Turner syndrome. One case 
underwent  vaginoplasty. 
Mashchak et  al., 1981, Shearman and Roberts  et  al., 1982,  
Sebanti  et  al., 2005  showed that the commonest cause for primary 
menorrhea was mullerian agenesis ( MRKH syndrome). 
In the present study, the commonest cause of of primary 
amenorrhoea with normal secondary sexual characteristics was  mullerian 
agenesis ( MRKH syndrome) 33.3%. Common cause of primary 
amenorrhoea with delayed secondary sexual characteristics were 
(Garden et  al., 1998, Edmond  et al., 1999 ) 
i) Turner syndrome  
ii) Gonadotrophin deficiency 
iii) Constitutional delay 
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In present study, Turner syndrome is the commonest cause of 
primary amenorrhoea with delayed secondary sexual character. 
 
2) Oligomenorrhoea  :  
Oligomenorrhoea is the most common  menstrual complaint in the 
present study (57.4%). Morgan and London  et  al., 1993 showed that 
the most common cause of oligomenorrhoea is HPO axis followed by 
causes like PCOS, stress, thyroid disorder etc. In the present study, HPO 
axis dysfunction was the most common cause of oligomenorrhoea 
accounting for 74.04% 
Prevalence of menstrual disorders in various studies  
Study group Percent 
Balasubramanian et al , 2000 26.62% 
Goswami et al , 2005 58.8% 
Kulkarni et al , 2011 11.16% 
Present study 55.1% 
 
PCOS (20.8%) is the second most common cause of  
oligomenorrhoea  followed by  hypothyroidism (3.47%). PCOS which 
was diagnosed based on the clinical criteria of menstrual dysfunction, 
hyperandrogenism and ultrasonographic findings.  
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There were 14/24 cases of PCOS who presented with complain of 
oligomenorrhoea and 10 cases presented with menorrhagia.  PCOS is the 
cause of menstrual irregularities in 24/114 (21.0%) cases in the present 
study which is comparable to the finding of 22.9% in the study conducted 
by Archana  et al ( 2013). 
In the present study, the most least common cause of menstrual 
irregularities is polymenorrhoea (0.9%). 
 
3) Puberty menorrhagia : 
 Puberty menorrhagia accounts for 19.8% of all menstrual 
complains in the present study. 10 out of 28 cases were admitted in our 
hospital and 4 cases had severe anaemia and 2 moderate anaemia, which 
required blood transfusion. 
 
 Most of cases of puberty menorrhagia had anaemia ranging from 
mild to severe, predominantly anemia ranging from haemoglobin 
percentage of 8.1- 10.9 gm%. Anaemic patients were treated with 
haematinics both oral and parenteral preparation, hormones and blood 
transfusion wherever indicated. 
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4) Dysmenorrhoea : 
 Primary dysmenorrhoea was presenting complaint in 10 cases out 
of total 18 girls in the present study group. In rest of 8 cases, 
dysmenorrhoea was an associated complain with other complains of 
menstrual irregularities .3 out of 10 cases had problem severe enough to 
prevent them from going to school. These girls on detailed history 
elicitation, their mother and sibling also had similar history of severe 
dysmenorrhoea. Dickens et al., also mentioned family history of primary 
dysmenorrhoea. 
Prevalence of dysmenorrhoea was high in late adolescent age 
group. Balasubramanian et al., 2000 and Rehman et al .,2004 also 
reported similar study findings. 
 
5) Leucorrhoea : 
 In this study, 51 cases (21.07%) of vaginal discharge was the second 
most commonest complaint in the adolescent girls. Most of them had 
physiological leucorrhoea which responded to counseling and 
maintenance of personal hygiene. 
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6) Ovarian tumor : 
Ovarian tumor were found in 5/150 cases (3.3%) . Out of  these 2 
had simple serous cysts and 1 with twisted ovarian cyst. There were 2 
cases of malignant ovarian tumour which turned out to be a case of 
Juvenile granulosa cell tumor and Yolk sac tumor confirmed by 
histopathological studies. Sebanti et al., 2005 and Archana et al., 2013 
have reported a higher incidence of ovarian tumor in their series, 15.3% 
and 4.5% respectively. 
 
Study group Incidence % 
Oumachigui  et al. 6% 
Dhamne et al. 2.25% 
Huggmen et al. 1% 
Sebanti et al. 15.3% 
Archana et al. 4.5% 
Present study 3.3% 
 
Two cases in the study presented with bartholin cyst, out of  which 
one case was of recurrent  bartholin cysts turning to bartholin abscess,was 
treated by drainage and antibiotic. Another case presented with injury to 
perineum, due to sexual assault. 
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SUMMARY 
• Low socio economic group coming from urban population was the 
maximum group of girls studied. 
• Maximum incidence of gynaecological problems was seen in the 
age group of 17 years. 
• Among the various presenting complaints in studied adolescent 
girls, menstrual irregularities were the most common. 
• Oligomenorrhoea was the most common menstrual problem in this 
study. 
• Anovulation is the most common cause of menorrrhagia in 
adolescents. 
• Majority of teenage (81.2%)  suffered from anemia ranging from 
mild to severe types of anaemia. 
• 21.42% patients with  puberty  menorrhagia received blood 
transfusion. 
• The most commonest cause of oligomenorrhoea was the 
Hypothalamic -pituitary – gonadal axis dysfunction. 
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• Counseling and reassurance was an integral part of treatment 
strategies. 
• PCOS and hypothyroidism were the other endocrinological 
abnormalities common among the adolescent girls. 
• Dysmenorrhoea was more common among the late adolescent age 
group. 
• Leucorrhoea in adolescent girls in the present study were most 
commonly physiological, counseled and explained to maintain 
proper hygiene.  
• MRKH Syndrome (Mullerian agenesis) is the commonest cause of 
primary amenorrhoea. 
• A combined effort of team comprising gynaecologist, 
endocrinologist, genetist is required in arriving the final diagnosis 
of in cases of primary amenorrhoea. 
• In the present study benign ovarian tumor were more common than 
malignant ovarian tumor. 
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CONCLUSION 
Adolescent gynaecology is an important sub- specialized part of 
gynaecology. The importance of the reproductive health problems among 
the adolescent has emerged tremendously during recent years. 
Endocrinal abnormalities like PCOS are associated with future 
reproductive as well as metabolic morbidity. Therefore, it is very 
important to evaluate and manage endocrinal abnormalities in adolescent 
properly so as to secure a healthy reproductive life. 
Menorrhagia, at all stages of life severely affects the quality of life. 
Effective management of puberty menorrhagia is mandatory in order to 
avoid adolescent with anaemia. As mentioned earlier, adolescent girls 
being the direct reproducer of future generation, it is important to avoid 
adolescent embarking on pregnancy with anaemia, which in long run 
reduce perinatal and maternal morbidity and mortality. 
Teenage problems need to be dealt with utmost sensitivity. 
Counseling teenage girls as well as parents is an integral part of the 
treatment strategies. Awareness regarding health, nutrition and hygiene 
should be included in the counseling in order to curtail problems like 
anemia, leucorrhoea. 
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Though, adolescent gynaecology is not a new subject. But, it still 
needs greater attention and increased awareness, in order to protect and 
promote the health of adolescents. As the problems are specific to this 
age group, setting up of a separate ‘Adolescent Gynaecological Clinics’ is 
the need of the hour. 
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PROFORMA 
 
Name : 
Address : 
Age :  
OP/IP No. : 
Height : Weight : BMI :  
Educational Status :  
Occupation : 
Marital Status : 
MENSTRUAL HISTORY : 
• Age of Menarche 
• LMP 
• Duration of Cycles 
• Amount of Bleeding 
• Number of Pads / Clothes used per day 
• Associated Complaints 
CHIEF COMPLAINTS : 
(A) Menstrual Abnormalities : 
• Amenorrhoea : 
• Menorrhagia 
• Oligomenorrhoea 
• Polymenorrhoea 
• Hypomenorrhoea, etc 
(B) Dysmenorrhoea 
(C) Lower Abdominal Pain 
(D) Leucorrhoea 
(E) Abdominal Mass 
(F) Pre Menstrual Syndrome 
(G) Others 
GENERAL EXAMINATION  
• Thyroid Examination 
• Breast Examination 
• Secondary Sexual Characters 
• CVS 
• RS 
CLINICAL EXAMINATION 
• P/A 
• P/V 
• P/R 
INVESTIGATIONS 
ULTRASOUND  
PROVISIONAL DIAGNOSIS  
 
ABBREVIATION 
 
WHO   –  World Health Organisation 
GH    – Growth Hormone 
IGF-I    – Insulin like growth factor-1 
FSH    – Follicular stimulating hormone 
LH    – Luteinising hormone 
TSH    – Thyroid stimulating hormone 
FT3    – Free Tri iodothyronine 
FT4    – Free Tetraiodothyronine 
GnRH   – Gonadotropin Releasing Hormone 
DHEA-S  – Dehydroandroepisterone-sulfate 
VNTR   – Variable number tandem repeat 
PCOS   – Polycystic Ovarian Syndrome 
USG    – Ultrasonography 
E2    – Estradiol 
LPD    – Luteal Phase Defect 
OCP    – Oral Contraceptive Pills 
PT    – Prothrombin Time 
ApTT   – Partial Thromboplastin Time 
BEP    – Bleomycin, Etoposide,  
VBC    – Vincristine, Bleomycin , Cisplatin 
VAC   - Vinblastin, actinomycin, cyclophosphamide 
 
INFORMATION SHEET  
 
• We are conducting a study on “STUDY ON ADOLESCENT 
GYNAECOLOGICAL PROBLEMS” among patients attending 
Kasturba Gandhi Government Hospital Chennai and for that your 
clinical details may be valuable to us. 
• We are selecting certain patients and if you are found eligible, we 
may be using your clinical details in such a way so as to not affect 
your final report or management. 
• The privacy of the patients in the research will be maintained 
throughout the study. In the event of any publication or 
presentation resulting from the research, no personally identifiable 
information will be shared. 
• Taking part in this study is voluntary. You are free to decide 
whether to participate in this study or to withdraw at any time; your 
decision will not result in any loss of benefits to which you are 
otherwise entitled. 
• The results of the special study may be intimated to you at the end 
of the study period or during the study if anything is found 
abnormal which may aid in the management or treatment. 
 
 
Signature of investigator      Signature of participant 
 
 
Date:                 Signature of parent                    
                                          (if minor) 
CONSENT FORM 
 
 
STUDY TITLE : STUDY ON ADOLESCENT GYNAECOLOGICAL PROBLEMS 
 
 
 
STUDY CENTRE : Institute of Social Obstetrics,  
                                             Govt. Kasturba Gandhi Hospital, 
                                             Chennai-5. 
 
PARTICIPANT NAME :    AGE:    O.P.NO./ I.P NO. 
 
 
 
 I confirm that I have understood the purpose of procedure for the above study, I have the 
opportunity to ask the question and all my questions and doubts have been answered to my 
satisfaction. I understand that my participation in the study is voluntary and that I am free to 
withdraw at any time without giving any reason. 
 
 I understand that investigator, regulatory authorities and the ethics committee will not 
need my permission to look at my health records both in respect to the current study and any 
further research that may be conducted in relation to it, even if I withdraw from the study.  I 
understand that my identity will not be revealed in any information released to third parties of 
published, unless as required under the law.  I agree not to restrict the use of any or results that 
arise from the study. 
 
 I hereby consent to participate in this study of STUDY ON ADOLESCENT GYNAECOLOCICAL 
PROBLEMS 
 
 
Signature of Investigator:     Place : 
        Date  : 
         
 
Study Investigators Name     Institution 
 
 
Signature / Thumb Impression of patient 
 
 
Signature of parent(if minor) 
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1. 
Kavitha 107,065 17 2 3 2 2 147 36 1 1        1  2 2 3 1 1 1 1 1 2 1 
2. 
Bharathi 180,515 19 2 4 3 2 147 36 1 1        1  2 2 3 1 1 1 1 1 2 1 
3. 
Banu 175,880 17 2 4 3 2 152 44 2 1        1  2 1 2 1 1 1 1 1 2 1 
4. 
Monisha 118,091 14 1 4 2 2 145 44 2 1          2 2 2 1 1 1 1 3 2 1 
5. 
Rohini 113,082 18 2 5 3 2 160 68 2 1 1       1  2 2 2 1 1 1 1 3 2 1 
6. 
Priya 24,734 17 2 3 2 2 156 63 3   1      1  1 2 2 1 2 1 1 3 2 1 
7. 
Vanishri 11,350 16 2 5 2 2 145 55 5 1 1    1     2 2 2 1 2 1 1 2 2 3 
8. 
Anandhi 127,560 17 2 5 2 2 152 48 2    1     1  2 2 4 3 0 1 1 0 5 0 
9. 
 Zeenat 153,720 17 2 4 2 2 152 48 2 1 1         2 2 2 1 1 1 1 3 2 1 
10. 
Iswarya 137,690 17 2 4 2 2 150 43 2 1 1         2 2 2 1 1 1 1 3 2 1 
11. 
Pavitra 145,209 17 2 5 2 2 152 48 2 1   1       2 2 2 1 1 1 1 3 2 1 
12. 
Ashwini 130,473 16 2 5 2 2 147 42 2  1  1       2 2 2 1 2 1 1 2 2 3 
13. 
Shakila 163,520 15 1 3 2 2 148 59 3   1      1  1 1 2 1 1 2 1 1 2 2 
14. 
Sangeeta 132,807 15 1 3 2 1 148 35 1 1  1   1   1  1 2 2 1 1 1 1 1 3 1 
15. 
Jayanthi 164,098 17 2 5 3 1 157 66 3 1  1      1  1 2 2 1 2 1 1 2 3 3 
16. 
Sneha 154,109 13 1 4 1 2 147 36 1    1       2 2 3 3 0 1 1 0 5 0 
17. 
Bhavani 134,209 17 2 4 2 1 155 44 1 1   1       2 2 4 1 1 1 1 1 2 1 
18. 
Ramya 111,542 17 2 4 2 1 155 44 1 1   1       2 2 3 1 1 1 1 1 3 1 
19. 
Divya 113,843 19 2 4 3 1 148 40 2 1          1 2 4 1 2 1 1 1 3 3 
20. 
Shanthi 124,351 19 2 4 3 2 155 68 3 1          2 1 2 1 2 1 1 2 3 3 
21. 
Surya 113,919 15 1 5 2 2 160 41 1    1       2 2 3 3 1 1 1 0 5 0 
22. 
Deepa 117,630 19 2 5 3 1 148 40 2 1   1       2 1 3 1 1 1 1 1 2 1 
23. 
Ishrat 178,023 18 2 5 3 1 148 40 2 1   1       2 2 2 1 1 2 1 3 2 1 
24. 
Ashwini 197,306 16 2 4 2 2 144 38 1 1          2 2 2 1 1 1 1 3 2 1 
25. 
Sowmya 174,056 18 2 3 3 2 152 63 3 1     1     1 1 2 1 2 1 1 2 2 3 
26. 
Kowsalya 219,054 17 2 3 2 1 148 40 2  1  1       2 2 4 1 1 1 1 1 2 2 
27. 
Suguna 201,367 16 2 4 2 2 148 40 2 1 1         2 2 2 1 1 1 1 1 3 1 
28. 
Mary 201,256 17 2 4 2 2 155 48 1 1 1         2 2 2 1 1 1 1 1 3 1 
29. 
Firtosh 153,289 18 2 5 3 2 148 40 2 1        1  1 2 4 1 1 1 1 1 2 1 
30. 
Tenmozhi 195,604 19 2 5 3 1 149 38 1 1 1         2 2 3 2 1 1 1 1 2 1 
31. 
Sulekha 153,729 16 2 5 2 2 152 60 3 1        1  1 2 3 1 2 1 1 2 2 3 
32. 
Pooja 115,024 19 2 4 3 2 155 48 2     1      2 2 4 2 3 1 1 0 6 7 
33. 
Sneha 164,523 13 1 4 2 2 155 48 2 1 1         2 2 3 1 1 1 1 3 2 1 
34. 
Madhavi 172,094 15 1 4 2 2 145 50 2    1 1      2 2 3 3 0 0 1 0 5 0 
35. 
Kalaivani 152,703 15 1 4 2 2 148 40 2    1       2 2 2 3 0 0 1 0 5 0 
36. 
Srinithi 151,638 14 1 4 2 2 148 40 2 1 1         2 2 1 3 1 2 1 2 2 3 
37. 
Sonia 181,626 17 2 5 3 1 145 55 3    1  1    1 2 2 3 3 1 0 1 0 6 7 
38. 
Gayathri 146,288 13 1 4 2 2 146 50 2    1 1      2 2 4 3 0 0 1 0 5 0 
39. 
Subatha 181,420 19 2 3 3 2 149 38 1 1   1       2 2 4 1 1 1 1 1 2 1 
40. 
Iswarya 178,390 15 1 4 2 2 150 30 2 1 1      1   1 1 2 1 1 2 1 2 3 2 
41. 
Preethi 172,653 14 1 4 2 1 147 42 2 1 1         2 2 2 1 1 1 1 1 2 1 
42. 
Hemavati 182,749 18 2 5 3 2 155 44 1 1   1       2 2 2 1 1 1 1 1 2 1 
43. 
Tenmozhi 192,731 18 2 4 3 2 144 40 2 1   1       2 2 2 1 1 1 1 3 2 1 
44. 
Puspa 193,762 17 2 5 3 2 153 41 1 1   1       2 2 2 1 1 1 1 3 2 1 
45. 
Nandini 201,735 17 2 4 2 1 148 40 2 1 1         2 1 1 1 2 1 1 2 3 3 
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46. 
Kavitha 218,301 15 1 5 2 1 145 52 2   1        2 2 2 1 1 1 1 1 4 1 
47. 
Malathi 216,800 19 2 3 3 2 144 40 2   1      1  1 1 2 1 2 2 1 1 3 3 
48. 
Anitha 201,783 18 2 4 1 2 148 40 2   1      1  1 2 2 1 1 1 1 3 3 1 
49. 
Manjula 203,641 17 2 3 2 2 147 36 1 1        1  1 1 3 1 1 1 1 3 3 1 
50. 
Viji 216,720 15 1 4 2 2 147 36 1 1    1      2 2 3 1 1 1 1 3 2 1 
51. 
Nazreen 183,920 19 2 4 3 2 147 42 2 1    1      2 2 3 1 1 1 1 3 2 1 
52. 
Vani 190,367 19 2 4 3 2 150 43 2          1 2 2 2 3 1 1 1 0 6 7 
53. 
Iswarya 200,012 13 1 4 2 1 144 40 2 1        1  1 2 3 1 1 1 1 3 2 1 
54. 
Surya 172,293 17 2 4 2 2 150 43 2 1   1       2 2 3 3 1 1 1 3 2 1 
55. 
Rekha 172,923 18 2 4 3 2 148 40 2    1       2 2 4 3 1 1 1 0 5 0 
56. 
Kalairasi 160,279 13 1 4 2 1 142 36 1    1       2 2 4 3 1 1 1 0 5 0 
57. 
Beula 182,630 13 1 5 1 1 147 36 1 1    1      2 1 2 1 2 1 1 2 2 3 
58. 
Lavanya 215,261 15 1 5 2 2 144 40 2 1    1      2 2 2 1 1 1 1 1 2 1 
59. 
Ratna 202,435 18 2 5 3 2 150 43 2 1    1      2 2 3 1 1 1 1 1 3 1 
60. 
Divya 209,817 13 1 5 2 1 142 36 1    1 1      2 2 3 3 1 1 1 0 5 0 
61. 
Sangitha 207,639 15 1 4 2 2 147 42 2 1  1        1 2 2 1 0 1 1 3 3 1 
62. 
Gomathy 182,773 18 2 5 1 2 144 40 2    1     1  1 2 3 3 1 1 1 0 5 0 
63. 
Karpagam 170,274 17 2 4 3 2 147 42 2 1 1         2 2 2 1 1 1 1 3 2 1 
64. 
Usha 172,927 19 2 4 3 2 155 70 4 1  1   1     2 1 2 1 1 2 1 2 2 3 
65. 
Divya 187,209 19 2 4 3 2 147 42 2 1   1       2 2 2 1 1 2 1 1 2 3 
66. 
Soundarya 187,735 13 1 3 1 2 147 42 2   1 1       2 2 3 1 1 1 1 3 2 1 
67. 
Sujatha 198,364 19 2 4 3 1 155 70 4 1   1  1   1  2 2 4 3 1 1 1 3 2 1 
68. 
Karpagam 193,024 17 2 4 2 2 147 42 2 1 1         2 2 3 1 1 1 2 1 2 5 
69. 
Rajlaxmi 210,936 18 2 5 3 2 155 44 1    1     1  2 2 3 3 0 1 1 0 5 0 
70. 
Monisha 207,351 19 2 5 3 2 154 50 2    1       2 2 3 3 0 1 1 0 5 0 
71. 
Sonia 209,864 16 2 5 2 2 155 52 2    1       2 2 2 3 0 1 1 0 5 0 
72. 
Susmitha 218,392 15 1 3 2 1 147 42 2   1        2 1 2 1 1 1 1 1 2 3 
73. 
Monisha 204,662 15 1 3 2 1 148 40 2 1   1       2 2 4 1 1 1 1 1 2 1 
74. 
Jamuna 209,374 17 2 4 3 2 145 52 2   1        2 2 2 1 1 1 1 1 2 1 
75. 
Sonia 196,381 16 2 4 2 2 150 30 1 1   1       2 2 2 1 1 1 1 3 2 1 
76. 
Monica 194,465 17 2 4 1 2 144 40 2 1   1       1 2 2 1 1 1 1 3 2 1 
77. 
Nandini 198,273 18 2 4 3 2 147 42 2 1          1 2 2 1 1 1 1 3 2 1 
78. 
Anitha 201,982 16 2 4 2 2 147 42 2 1          1 2 2 1 1 1 1 3 2 1 
79. 
Pavithra 218,221 13 1 3 2 2 150 30 1   1      1  2 2 3 1 1 1 1 3 2 1 
80. 
Vaisnavi 219,301 15 1 4 2 2 144 40 2    1       2 2 3 3 0 1 1 0 5 0 
81. 
Bhavani 210,372 19 2 4 3 2 152 63 3 1    1 1    1 2 2 2 1 3 1 1 0 6 7 
82. 
Priya 201,836 13 1 4 1 2 144 52 3 1   1       2 1 3 1 2 1 1 2 2 3 
83. 
Vinodini 207,764 14 1 4 2 2 150 30 1    1     1  1 2 2 3 0 1 1 0 5 0 
84. 
Chandra 214,253 15 1 5 2 2 146 50 2    1       2 2 3 3 0 1 1 0 5 0 
85. 
Shobana 212,837 19 2 5 3 2 155 48 2    1       2 2 4 3 0 1 1 0 5 0 
86. 
Laxmi 213,840 19 2 5 1 2 155 48 2 1          2 2 2 1 1 1 1 1 2 1 
87. 
Meena 217,003 19 2 5 3 2 145 59 3    1       1 2 4 1 0 1 1 1 2 1 
88. 
Selvi 218,324 18 2 3 3 2 150 60 4 1     1   1  2 1 2 1 2 1 1 1 2 3 
89. 
Jannat 217,820 14 1 5 2 2 144 40 2 1    1      2 2 2 1 1 1 1 1 2 1 
90. 
Vidya 219,032 14 1 5 2 2 146 50 2    1       2 2 2 3 0 1 1 0 5 0 
S
.N
o
 
NAME 
O
P
IP
N
O
 
A
G
E
 
A
G
E
_
G
 
S
E
S
 
E
D
N
 
L
O
C
A
L
IT
Y
 
H
T
 
W
T
 
B
M
I 
C
o
m
.1
 
C
o
m
.2
 
C
o
m
.3
 
C
o
m
.4
 
C
o
m
.5
 
C
o
m
.6
 
C
o
m
.7
 
C
o
m
.8
 
C
o
m
.9
 
C
o
m
 0
 
G
O
IT
R
E
 
H
IR
S
U
T
IS
 
H
B
 
X
R
A
Y
 
U
S
G
 
T
S
H
 
P
L
 
L
H
 
D
IA
G
N
O
S
I 
C
A
U
S
E
 
91. 
Nithya 208,936 19 2 4 3 2 147 36 1   1        2 2 2 1 1 1 1 3 2 1 
92. 
Kavitha 207,593 17 2 4 2 2 152 44 2   1        2 2 2 1 1 1 1 3 2 1 
93. 
Swathi 213,750 15 1 4 2 2 147 36 1   1        2 2 2 1 1 1 1 3 2 1 
94. 
Kavitha 209,375 19 2 3 3 2 147 36 1   1        2 2 2 1 1 1 1 1 2 1 
95. 
Nivetha 216,354 14 1 3 2 2 147 42 2   1        2 2 2 1 2 1 1 2 2 3 
96. 
Arulmothi 218,364 16 2 4 2 1 147 42 2     1      2 2 3 1 1 1 1 0 6 7 
97. 
Latha 214,673 17 2 4 2 2 145 44 2   1 1       2 2 2 1 1 1 1 1 3 1 
98. 
Ayesha 216,480 19 2 5 1 2 147 42 2   1        2 2 2 1 1 1 1 3 3 1 
99. 
Janani 219,333 19 2 4 3 2 147 58 4   1   1     2 2 2 1 2 1 1 1 2 3 
100. 
Sandhya 215,730 16 2 5 2 2 155 70 3 1   1       2 1 2 1 2 2 1 2 3 3 
101. 
Thilaga 215,300 16 2 5 2 2 155 67 3 1   1  1     2 2 2 1 2 2 1 2 3 3 
102. 
Meena 215,361 17 2 4 1 2 147 36 1 1          2 2 4 1 1 1 1 1 3 1 
103. 
Sasirekha 214,772 18 2 5 1 1 147 42 2 1   1       2 2 4 1 1 1 1 3 3 1 
104. 
Lilly 215,801 14 1 4 2 2 144 40 2 1          2 2 2 1 1 1 1 3 3 1 
105. 
Uma 215,623 14 1 4 2 2 147 42 2 1 1         2 2 2 1 1 1 1 3 3 1 
106. 
Geetha 230,281 18 2 5 3 1 162 38 1 1          2 2 3 1 0 1 1 3 2 1 
107. 
Manjula 220,001 18 2 4 3 1 155 44 1  1   1  1    2 1 2 1 1 1 1 3 3 1 
108. 
Suraya 243,818 17 2 3 2 2 144 40 2 1   1       2 2 1 1 1 1 1 1 3 1 
109. 
Gayathri 220,934 17 2 4 2 2 144 40 2 1          2 2 2 1 1 1 1 1 3 1 
110. 
Kamatchi 228,493 15 1 4 2 2 155 77 4 1     1   1  2 1 1 1 1 1 1 1 2 4 
111. 
Vanaja 220,193 17 2 4 3 2 155 52 2   1        2 2 2 1 2 2 1 1 2 1 
112. 
Jothi 230,647 14 1 4 2 2 157 62 3   1        1 2 2 1 2 2 1 1 1 1 
113. 
Rosy 235,180 16 2 4 2 2 162 38 1   1        1 2 2 1 1 1 1 1 3 1 
114. 
Radhika 246,751 17 2 4 1 1 162 38 1   1        2 2 2 1 1 1 1 3 3 1 
115. 
 Nithya 224,132 17 2 4 1 1 155 48 2   1        2 2 2 1 1 1 1 3 3 1 
116. 
Saraswati 234,521 15 1 3 1 2 155 48 2  1     1 1   1 1 4 1 1 1 1 1 3 2 
117. 
Sujatha 230,012 19 1 3 2 2 147 42 2   1        2 2 2 2 2 1 1 1 2 1 
118. 
Kumari 248,321 15 1 5 2 2 147 54 3   1        2 2 2 1 2 1 1 3 3 1 
119. 
Deepa 241,979 15 1 5 2 1 148 56 3 1          2 2 3 1 2 1 1 1 3 3 
120. 
Sharmila 248,723 17 2 4 3 2 147 42 2 1 1         2 2 2 1 1 1 1 3 3 1 
121. 
Sophi 210,294 17 2 4 2 2 146 50 2 1   1       2 2 3 1 3 1 1 2 2 3 
122. 
Shanthi 221,902 18 2 4 3 2 155 48 2 1 1         2 2 2 1 1 1 1 1 2 1 
123. 
Shylaja 231,562 18 2 4 3 2 155 48 2 1 1         2 2 4 1 1 1 1 1 2 1 
124. 
Harini 240,961 17 2 4 2 1 146 50 2 1 1         2 2 2 1 1 1 1 1 2 1 
125. 
Devaki 245,371 16 2 5 2 2 152 63 3 1 1         2 2 3 1 1 1 1 1 2 1 
126. 
Devi 259,102 16 2 5 2 2 155 48 1 1   1       2 2 2 1 1 1 1 1 2 1 
127. 
Tulasi 251,833 19 2 5 3 2 154 63 2 1          1 2 2 1 1 1 1 3 2 1 
128. 
Jotilaxmi 260,012 19 2 5 3 1 154 54 2 1          1 2 4 1 1 1 1 3 2 1 
129. 
Raji 275,201 18 2 5 3 2 150 80 5 1     1   1  1 1 2 1 2 1 1  2 3 
130. 
Sumathy 278,192 14 1 5 2 2 155 52 2 1   1       2 2 2 1 1 1 1 3 2 1 
131. 
 Ramya 279,012 18 2 4 3 2 145 59 3 1          2 2 3 1 1 1 1 3 2 1 
132. 
Banu 282,362 16 2 3 2 1 155 48 1    1       2 2 2 3 0 1 1 0 5 0 
133. 
Sindu 270,912 16 2 3 2 2 147 40 2    1       2 2 3 3 0 1 1 0 5 0 
134. 
 Divya 256,091 19 2 4 1 2 145 55 3 1   1       2 2 4 1 1 1 1 1 2 1 
135. 
Kamatchi 245,612 19 2 5 3 2 153 55 2 1        1  1 1 2 1 2 1 1 1 2 3 
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136. 
Vasugi 260,456 19 2 4 3 2 153 41 1 1          1 2 4 1 1 1 1 1 2 1 
137. 
Renuka 271,891 18 2 5 3 1 155 48 1 1 1         2 2 2 1 1 1 1 1 2 1 
138. 
Nithya 289,012 18 2 5 3 1 153 41 1 1 1         2 2 2 1 1 1 1 1 2 1 
139. 
Rani 281,282 18 2 4 1 2 149 38 2  1         2 2 4 1 1 1 1 3 2 1 
140. 
Priyadarsini 290,128 13 1 4 1 2 147 40 2 1  1  1     1 2 2 3 1 3 1 1 0 6 7 
141. 
Susila 290,123 14 1 5 2 2 146 50 2    1       2 2 3 3 0 1 1 0 5 0 
 
 
 
1. Age Group in years  
  1 → 13 – 15 years  
  2 → 16 – 19 years  
 
2. Socio economic Status  
  3 → Class III  
  4 → Class IV  
  5 → Class V  
 
3. Educational status  
  1 → Primary  
  2 → Secondary  
  3 → Higher Secondary  
 
4. Localities   
  1 → Urban  
  2 → Rural  
 
5. Body Mass Index (BMI)   
  1 → ≤ 19 (Under weight)  
  2 → 20 – 24 (Normal)  
  3 → 25 – 29 (over weight) 
  4 → 30 – 34 (Obese)  
  5 →  ≥ 35 (Morbid obesity)  
 
6.  Complaints  
  1 - Irregular Periods 
  2 - Scanty Periods  
  3 - Profuse prolonged bleedings P/v  
  4 - White discharge p/v 
  5 - lower abdominal pain  
  6 - Excessive weight gain  
  7 - increased hair growth over face  
  8 - Neck swelling  
  9 - Dysmenorrhoea 
 
7. Goitre  
  1 - Present  
  2 - Absent  
8.  Hirsution  
  1 → Present  
  2 → Absent  
 
9. Hb%  1 → Normal (≥ 12 gm %)  
   2 → Mild (11.0 - 11.0 gm %)  
   3 → Moderate (8.1 – 10.9)  
   4 → Severe (< 9 gm %)  
 
10.  USG 0 → Not done 
   1 → Normal 
   2 → PCOS 
   3 → T.O. Mass  
 
11. TSH  1 → Normal  
   2 → High  
 
12.  PL  1 → Normal  
   2 → Not done  
    0 → High  
 
13. LH   1 → Normal  
   2 → High  
 
14. Diagnosis  1 → Oligomenorrhoea 
   2 → Menorrhagia 
   3 → PCOS  
   4 → Polymenorrhoea  
   5 → Leucorrhoea 
   6 → Others       
 
15. Cause  0 →  Leucorrhoea  
   1 → HPO axis dysfunction  
   2 → Hypothyroidism  
   3 → PCOS  
   4 → Polymenorrhoea  
   5 → Hyperprolactinaemia  
   6 → Thyroditis  
   7 → Others
sl no. Name IP/OP no. Age SE EDU U/R Ht Wt BMI Arm span Consan Compl Breast Ax. Hair Pub hair som Abn Hirstut Ext gen Vag Uterus Ovaries met abn TSH K-typ Dx Cause 
1 Gomathy 10385 18 IV S U 160 58 22.1 140 Non 1 IV 2 2 NIL NIL 1 3 3 1 NIL 1.85 46XX A 3 
2 Sowmya 34289 15 IV P U 132 51 29.27 120 II 1 I 3 3 P NIL 2 2 1 3 NIL 3.9 45X0 A 1 
3 Puspalata 45342 17 IV S U 146 40 18.77 142 Non 1 II 3 3 NIL NIL 2 2 1 3 NIL 1.925 46XX A 5 
4 Ayesha 37890 17 IV S U 135 34 18.66 138 Non 1 II 3 1 NIL NIL 1 1 1 1 NIL 3.01 46XX A 4 
5 priyadarshini 43890 16 IV S U 132 39 22.38 130 Non 1 I 3 3 P NIL 2 2 2 3 NIL 0.75 45X0,46XX A 2 
6 jenifer 12546 18 V S U 145 33 15.7 140 III 1 I 2 2 NIL NIL 1 3 4 1 NIL 1.9 46XX A 3 
7 Akila 490045 15 IV S U 142 33 16.37 140 II 1 A 3 3 NIL NIL 2 1 3 1 NIL 1.75 46XX A 3 
8 Komala 23471 18 V P R 160 44 15.97 155 Non 1 III 2 2 P NIL 2 2 2 2 NIL 1.867 45X0 A 1 
9 Sathya 223100 16 IV S U 142 34  140 III 1 I 2 2 NIL NIL 2 3 4 1 NIL 1.254 46XX A 3 
 
  
Age in years  
1. Ht  - Height in CM  
2. Wt - Weight in Kg  
3. Arm – arm Span in CMS  
4. Cons – Consanguinity 
5. Complain – 1 – Primary Amenorrhoea  
6. Axl. Hair – 1 – Absent, 2 – Normal, 3 – Sparse 
7. Pubic Hair 
8. SAB – Somatic Abnormalities 
9. Ex. Gen – External Genitalia 1 – Normal, 2 – Infantile 
10. Vagina – 1 – Normal, 2 – Infantile, 3 – Dimple  
11. Uterus – 1 – Normal, 2 – Hypoplastic, 3 – Rudimentary, 4 – Absent  
12.  Met. Abn. – Matabolic Abnormalities  
13. USG – Ultra Sonographic 
14. Ovary – 1 – Normal, 2 – Streak, 3 – Absent  
15. SES – Socio Economic Status 
16.  Education : U – Uneducated, P – Primary,  S – Secondary,  H – Higher Secondary 
17. Locality : U – Urban, R – Rual 
18. Diagnosis : A – Primary Amenorrhoea 
19. Cause : 1 – Turner Syndrome, 2 – Turner Mosaic, 3 – MRKH (Mullerian Agenesis), 
 4 – Constitutional Delay, 5 – Pure  Gonadal Dysgenesis. 
 
